FDA Warning Letter Recipients: Where Are Their Claims Now?
This article was originally published in The Rose Sheet
Executive Summary
A key component of FDA’s enforcement strategy in the cosmetics space is monitoring companies’ websites for overreaching product claims and issuing warning letters accordingly. Examination of past offenders’ current sites and updated claims offers potential visibility into language the agency will and will not tolerate when it comes to promoting skin-care benefits.
New to HBW Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests:
